Glenmark gets USFDA nod for generic blood pressure medicine

Shares of Glenmark Pharmaceuticals were trading 2.17 percent up at Rs 625.20 on BSE

Indo Asian News Service|May 26, 2017, 14:01:19 IST

New Delhi, May 26 (PTI) Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic version Olmesartan Medoxomil Tablets, used in treatment of high blood pressure.[caption id="attachment_3108366" align="alignleft" width="380"] Representational image. Image courtesy: Agencies[/caption]The approval granted by the US Food and Drug Administration to Glenmark Pharmaceuticals Inc is for multiple strengths of 5 mg, 20 mg and 40 mg, the company said in a statement.These are generic equivalent of Benicar Tablets of Daiichi Sankyo, Inc. Glenmark's Olmesartan Medoxomil tablets will be manufactured by the company's manufacturing facility located in Goa, India, it added.Citing IMS Health sales data for the 12-month period ended March 2017, the company said Benicar achieved annual sales of about USD 950 million.Glenmark's current portfolio consists of 115 products authorised for distribution in the US market and approximately 69 ANDA's (Abbreviated New Drug Application) pending approval with the USFDA.Shares of Glenmark Pharmaceuticals were trading 2.17 percent up at Rs 625.20 on BSE.

Google burns cash for first time as AI spending pushes 2026 capex to $205 billion

Google parent Alphabet reported negative free cash flow of $5.9 billion in the second quarter for the first time since going public, as surging AI infrastructure spending pushed its 2026 capital expenditure forecast to as much as $205 billion

6 min read

Tesla sells more cars but makes less money: Why Musk’s AI pivot is squeezing profits

Tesla’s record Q2 deliveries failed to translate into higher profits as price cuts, falling regulatory-credit revenue and Elon Musk’s aggressive AI spending squeezed margins and pushed the EV maker into negative free cash flow

5 min read

No premium queues, 30-minute target: What changes for Indian passport applicants in UAE

Indian passport applicants in the UAE can now access passport, visa and attestation services through Alhind’s 16 centres, with no premium queues, a Dh19 service fee and a target of completing applications within 30 minutes

4 min read

Bharat Forge, Flying Whales sign pact to develop 60-tonne airships for India’s defence logistics

Bharat Forge has signed an MoU with Flying Whales to jointly develop and manufacture 60-tonne heavy-lift airships in India for defence logistics, strategic mobility and disaster response

3 min read

Air India to cut Delhi-Toronto flight time by 3 hours, resume non-stop services from August 1

Air India will resume non-stop Delhi-Toronto flights from August 1, cutting travel time by nearly three hours and deploying its new Boeing 787-9 Dreamliner on the route

2 min read

Up Next